Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials

Published:2012-12-03 Issue:2 Volume:15 Page:175-184
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ratner R. E.¹,Gough S. C. L.²,Mathieu C.³,Del Prato S.⁴,Bode B.⁵,Mersebach H.⁶,Endahl L.⁶,Zinman B.⁷

Affiliation:

1. Division of Endocrinology, Department of Medicine, Georgetown University School of Medicine Washington DC USA

2. Oxford Centre for Diabetes Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre Oxford UK

3. University Hospitals (UZ) Leuven KU Leuven Leuven Belgium

4. University of Pisa Pisa Italy

5. Atlanta Diabetes Associates Atlanta GA USA

6. Novo Nordisk Søborg Denmark

7. University of Toronto Mount Sinai Hospital Toronto ON Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12032

Reference31 articles.

1. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

2. Relationship between lactate dehydrogenase and myeloperoxidase levels in human gingival crevicular fluid and clinical and microbial measurements

3. The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management

4. Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs

5. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study;Current Medical Research and Opinion;2024-09-05

2. Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials;Diabetes, Obesity and Metabolism;2024-07

3. Once-weekly insulin icodec versus once-daily long-acting insulins for type 2 diabetes mellitus: Systematic review and meta-analysis;Metabolism Open;2024-06

4. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

5. Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges;Current Pharmaceutical Biotechnology;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3